Skip to main content

Table 1 Demographical and clinicopathological characteristics of all the participants

From: Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer

Parameters PDAC group (N = 72) Healthy control group (N = 136) P value
Age, average ± standard error 59.54 ± 1.19 58.23 ± 0.75 0.379
Gender, n (%)
 Male 41(57%) 48(35%) 0.003
BMI, average ± standard error 22.03 ± 0.37 23.81 ± 0.30 < 0.0001
Smoking history, n (%) 22(31%) 19(14%) 0.004
Alcohol history, n (%) 25(35%) 19(14%) < 0.0001
Chronic disease, n (%)
 Hypertension 9(13%) 37(27%) 0.015
 Type II diabetes 13(18%) 15(11%) 0.158
CA199, average ± standard error 357.29 ± 42.28 /  
Jaundice 21(29%) 0 < 0.0001
Tumor size, average ± standard error 3.79 ± 0.19 /  
Primary cancer site, n (%)   /  
 Uncinate process 13(18%)   
 Head 29(40%)   
 Body 17(24%)   
 Tail 13(18%)   
Surgery, n (%)   /  
 Pancreaticoduodenectomy 26(36%)   
 Distal pancreatectomy 11(15%)   
 Palliative intervention techniques 35(49%)   
AJCC staging, n (%)   /  
 I 8(11%)   
 II 28(39%)   
 III 18(25%)   
 IV 18(25%)   
  1. BMI body mass index, CA199 carbohydrate antigen199, AJCC American Joint Committee on Cancer
  2. Note: P values were calculated using chi-squared test